Orally efficacious thrombin inhibitors with cyanofluorophenylacetamide as the P2 motif
Authors:
- 1 May 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (9) , 2865-2870
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- 2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitorsBioorganic & Medicinal Chemistry Letters, 2007
- Heart Disease and Stroke Statistics—2007 UpdateCirculation, 2007
- Evaluation and Management of Atrial FibrillationCardiovascular & Hematological Disorders-Drug Targets, 2006
- Arginine Mimetic Structures in Biologically Active Antagonists and InhibitorsCurrent Medicinal Chemistry, 2006
- Exploration of Potential Prodrugs of RWJ‐445167, an Oxyguanidine‐based Dual Inhibitor of Thrombin and Factor XaChemical Biology & Drug Design, 2006
- Oxyguanidines. Part 2: Discovery of a novel orally active thrombin inhibitor through structure-based drug design and parallel synthesisBioorganic & Medicinal Chemistry Letters, 2004
- Metabolism-Directed Optimization of 3-Aminopyrazinone Acetamide Thrombin Inhibitors. Development of an Orally Bioavailable Series Containing P1 and P3 PyridinesJournal of Medicinal Chemistry, 2003
- Structure-Based Design of Novel Potent Nonpeptide Thrombin InhibitorsJournal of Medicinal Chemistry, 2002
- The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic EffectsThrombosis Research, 2001
- Design and synthesis of a novel class of thrombin inhibitors incorporating heterocyclic dipeptide surrogatesBioorganic & Medicinal Chemistry Letters, 1997